stephen silberstein, md, director, jefferson university headache center.
.
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
refrain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks, name calling or inciting hatred against any community.
.
.
by continuing to use this site you consent to the use of cookies on your device as described in our
. we value our readers and are committed to growing our community by encouraging you to add to the discussion.
.